High-Dose Deferoxamine in Intracerebral Hemorrhage
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Magdy Selim, MD, PhD
Beth Israel Deaconess Medical Center/Harvard Medical School
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Foothills Medical Center
Calgary, Alberta, Canada
- Mackenzie Health Sciences Centre
Edmonton, Alberta, Canada
- Halifax Infirmary
Halifax, Nova Scotia, Canada
- Hôpital de L'Enfant-Jésus - Chu de Québec
Québec, Canada
- St. Joseph'S Hospital
Phoenix, Arizona, United States
- Stanford University Hospital
Palo Alto, California, United States
- San Francisco General Hospital
San Francisco, California, United States
- Hartford Hospital
Hartford, Connecticut, United States
- Yale New Haven Hospital
New Haven, Connecticut, United States
- the University of Florida College of Medicine
Jacksonville, Florida, United States
- University of Iowa Hospital
Iowa City, Iowa, United States
- Johns Hopkins Hospital
Baltimore, Maryland, United States
- University of Maryland Medical Center
Baltimore, Maryland, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Tufts Medical Center
Boston, Massachusetts, United States
- University of Massachusetts Memorial Medical Center
Worcester, Massachusetts, United States
- Henry Ford Hospital
Detroit, Michigan, United States
- University of North Carolina Medical Center
Chapel Hill, North Carolina, United States
- Duke University Hospital
Durham, North Carolina, United States
- the Cleveland Clinic Foundation
Cleveland, Ohio, United States
- the Ohio State University Medical Center
Columbus, Ohio, United States
- Oregon Health & Science University
Portland, Oregon, United States
- University of Pennsylvania Medical Center
Philadelphia, Pennsylvania, United States
- Rhode Island Hospital
Providence, Rhode Island, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- the University of Texas Health Science Center
Houston, Texas, United States
- University of Virginia Health System
Charlottesville, Virginia, United States
- Harborview Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Mar 2013
- Primary completion
- 15 Jan 2014
- Completion
- 10 May 2018
- Last update posted
- 12 Jun 2019
- Registered enrollment
- 42
- Registry id
- NCT01662895
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.